Children’s Panadol recall

recall regulatory
GlaxoSmithKline is recalling three batches of Children’s Panadol due to possible contamination, the TGA has confirmed. The recall involves two batches of Children’s Panadol 5-12 Suspension Strawberry (200mL) and one batch of Children’s Panadol 5-12 Suspension Orange (200mL). It has been identified that an ingredient used in the manufacture of these medicines may have been

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacies warned on ‘cowboy’ behaviour
Next UK information expert keynote speaker at Pharmacy Connect